Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III trial of Dupixent for eosinophilic esophagitis meets coprimary endpoints

May 25, 2020

HCP5 is a diagnostic and prognostic marker in AML

May 25, 2020

Serum KL-6 as a biomarker for the management of Mycobacterium avium complex lung disease

May 25, 2020

Phase I/II data presented for LY-500307 in men with schizophrenia

May 25, 2020

GlaxoSmithKline plc synthesizes new H-PGDS inhibitors

May 25, 2020

Fidget spinner allows point-of-care diagnosis of UTIs

May 25, 2020

Roche synthesizes new TLR antagonists

May 25, 2020

Chinese investigators divulge coagulation factor XIa inhibitors

May 25, 2020

Beijing Tide Pharmaceutical patents ROCK2 inhibitors

May 25, 2020

FDA accepts IND application for phase I/II study of NT-219 in advanced cancer

May 25, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...